A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12–20 weeks gestation

By Tang Oi Shan   Chan Carina C.W.   Kan Anita S.Y.   Ho Pak Chung  

Human Reproduction, Vol. 20, Iss. 11, 2005-11 ,pp. : 3062-3066

Oxford University Press

Access to resources Recommend Favorite

Fertility control. Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation

By Bartley Julia   Brown Audrey   Elton Rob  

Human Reproduction, Vol. 16, Iss. 10, 2001-10 ,pp. : 2098-2102

Oxford University Press

Access to resources Recommend Favorite

A prospective, randomized, placebo‐controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks gestation

By Tang Oi Shan   Chan Carina C.W.   Ng Ernest H.Y.   Lee Sharon W.H.   Ho Pak Chung  

Human Reproduction, Vol. 18, Iss. 11, 2003-11 ,pp. : 2315-2318

Oxford University Press

Access to resources Recommend Favorite

The effect of non-steroidal anti-inflammatory drugs on medical abortion with mifepristone and misoprostol at 13–22 weeks gestation

By Fiala C.   Swahn M.L.   Stephansson O.   Gemzell-Danielsson K.  

Human Reproduction, Vol. 20, Iss. 11, 2005-11 ,pp. : 3072-3077

Oxford University Press

Access to resources Recommend Favorite

A randomized trial to compare two dosing intervals of misoprostol following mifepristone administration in second trimester medical abortion

By Chai J.   Tang O.S.   Hong Q.Q.   Chen Q.F.   Cheng L.N.   Ng E.   Ho P.C.  

Human Reproduction, Vol. 24, Iss. 2, 2009-02 ,pp. : 320-324

Oxford University Press

Access to resources Recommend Favorite